Oystershell Consumer Health

Oystershell Consumer Health is a Belgian healthcare company that specializes in the development and commercialization of innovative over-the-counter (OTC) products. Founded in 2002 by Bart Rossel, the company focuses on science-based solutions for common health issues, particularly in dermatology and insect protection. Their portfolio includes market-leading brands such as Elimax for head lice treatment and Mouskito for insect repellent, many of which utilize unique physical modes of action. Oystershell operates an integrated business model that combines internal R&D with global marketing partnerships. In 2022, the company was acquired by Cooper Consumer Health, further strengthening its position in the European consumer healthcare market.